# 1. Financial Performance ## A. Key Figures * **Revenue:** **₹193 Cr** Q4 (+11% QoQ) · **₹711 Cr** FY26 (+27% YoY) * **Operating EBITDA Margin:** **16%** FY26 (vs. 23% FY25) * **Profit After Tax (PAT):** **₹70 Cr** FY26 (-20.5% YoY) * **Return Ratios:** **19%** ROE · **20%** ROCE * **Working Capital Cycle:** **91 Days** (-8 days YoY) ## B. Revenue Growth * **Post-Acquisition Transformation:** Since the **March 2022** takeover, the company has achieved a five-fold top-line expansion, representing a robust **37% CAGR** over five years. * **Record Performance:** FY26 marked the highest-ever quarterly and annual revenue in the company's history, despite a specific segment revenue decrease of **₹17 Cr**. * **Intercompany Synergy:** Sales to parent company Anupam remain minimal at approximately **1.2%** of total revenue, conducted strictly at arm's length. ## C. Margins & Profitability * **Profitability Headwinds:** Bottom-line contraction was driven by lower operating profits, higher depreciation from CAPEX, and a **₹2.5–3 Cr** M2M loss due to rupee depreciation. * **Operational Disruptions:** Performance was significantly impacted by a **₹70 Cr** production loss at the HF-1 plant following unplanned maintenance and technical bottlenecks. * **Margin Outlook:** Management expects margins to stabilize between **15% to 18%**, with potential for a **3% to 4%** uplift following the introduction of R-32 revenue. * **Value Migration:** Transitioning from industrial to solar-grade HF offers a margin premium of **₹10 to ₹15 per kg**, supported by strong backward integration. ## D. Capital Allocation * **Aggressive Expansion:** A **₹495 Cr** CAPEX plan is underway, with **₹405 Cr** dedicated to the R-32 project, which is projected to generate **₹900–1,000 Cr** in annual revenue. * **Funding Strategy:** The R-32 project will be financed via **₹100 Cr** from promoters, with the remaining **₹300 Cr** sourced through a QIP and term debt. * **Long-term Visibility:** Backed by a **₹3,000 Cr+** long-term contract book, the company plans a further **₹500–700 Cr** investment over the next 3–5 years. * **Project Economics:** The HFC project maintains a highly attractive payback period of **less than four years** due to strong market realizations. --- # 2. Manufacturing & Capacity ## A. Key Figures * **Total Installed Capacity:** **1,35,000 MTPA** Integrated facility across **60 acres** * **HF Capacity:** **30,000 MTPA** Doubled from 15,000 MTPA in Oct 2024 * **Capacity Utilization:** **101%** Sulphuric acid plant · **95%** Hydrofluoric (HF) plant ## B. Production Utilization * **Record Operational Performance:** Achieved highest-ever production volumes and utilization levels in FY26, underpinned by enhanced downstream chemistry capabilities. * **Asset Restoration:** The HF-1 plant has returned to full operational capacity following the establishment of a solar grade plant, which added **₹7 Cr** to annual depreciation. ## C. Expansion Projects * **Cost Leadership in Execution:** Completed HF expansion at capital costs significantly below industry benchmarks; planning an additional **30,000-ton AHF facility** beyond the current budget. * **Downstream Roadmap:** Establishing a **20,000 MTPA** fluorinated products facility (Q3 FY27 commissioning) and secured environmental clearances for the upcoming HFC-32 plant. * **Strategic Backward Integration:** Capacity hikes in HF and Sulphuric acid are specifically engineered to support HFC-32 production and solar grade DHF expansion. ## D. Technology & Innovation * **High-Barrier Segments:** Focus shifting toward high-purity applications for semiconductors and photovoltaics; solar grade DHF production involves a **two-year learning curve** and standards comparable to CGMP. * **R&D Pipeline:** Long-term growth anchored by high-margin HFO refrigerant gases, battery chemicals, and fluoropolymers, with several products currently in the customer approval stage. * **Competitive Moat:** Advantage derived from in-house HF availability and integrated infrastructure, reducing reliance on external raw material sourcing for downstream expansion. --- # 3. Product & Market Mix ## A. Key Figures * **Solar Grade DHF Capacity:** **20,000 MTPA** Total commissioned capacity * **Order Book:** **₹1,050 Cr** Solar grade DHF (85% capacity utilization through FY29) * **Specialty Fluoride Utilization:** **41%** Current rate * **Domestic AHF Demand:** **~40 KT** Total (15 KT Solar · 15-18 KT Surface Treatment · ~10 KT Specialty) ## B. Solar Grade DHF * **First-Mover Advantage:** Established as India's sole manufacturer of solar grade DHF, targeting high-growth solar PV and semiconductor verticals. * **Superior Unit Economics:** Solar grade HF commands a premium realization of **₹15 to ₹20 per kg** over industrial grade, while incurring only **₹3 to ₹5 per kg** in incremental processing costs. * **Technical Barrier to Entry:** Sole-manufacturer status is protected by high technical requirements, specifically maintaining impurity levels at **less than 10 parts per billion (PPB)**. * **Revenue Visibility:** Significant multi-year order book has effectively locked in the majority of commissioned capacity for the next three fiscal years. ## C. Refrigerant Gas (HFC-32) & Specialty Fluorides * **HFC-32 Profitability:** Future growth to be anchored by downstream HFC-32 production; contracts utilize formula-based pricing with an expected payback period of **less than four years**. * **Strategic Diversification:** Pipeline is pivoting toward high-margin "next-gen" applications, including battery materials, electronic grade chemicals, and high-performance fluoropolymers. * **Operational Upside:** Current moderate utilization in specialty fluorides provides significant headroom for margin expansion as demand for value-added products scales. * **Corporate Structure:** Management confirmed a clear demarcation of product portfolios between TANFAC and its parent company, ensuring no overlap in fluorine downstream segments. --- # 4. Customer & Supply Chain ## A. Key Figures * **Solar Grade DHF Order Book:** **₹1,068 Cr** 3.5-year execution timeline * **Fluorinated Product Contracts:** **₹3,612 Cr** Total value · **5 to 7 years** Duration * **Capacity Pre-booking:** **65%** of upcoming plant (approx. **13,000-13,500 tonnes**) * **R-32 Production Cost:** **₹240 – ₹280 per kg** Estimated range ## B. Long-term Contracts * **High Revenue Visibility:** Significant long-term supplier arrangements and a major agreement with **Blue Star** provide a stable foundation for future growth. * **Strategic Capacity De-risking:** Management aims to secure **80% to 85%** of R-32 capacity via contracts prior to plant commissioning, with a heavy export tilt of **75% to 80%**. * **Contractual Safeguards:** Formula-based pricing for R-32 manages volatility, while mutual penalty clauses protect against volume defaults once production commences. * **Quota Contingency:** Agreements are structured to exclude liabilities or penalties related to potential **government quota non-allocation** contingencies. ## C. Raw Material Sourcing * **Supply Chain Resilience:** Diversified sourcing for fluorspar, sulphur, and potassium carbonate across multiple geographies to mitigate regional risks. * **MDC Surplus Advantage:** Domestic supply of Methylene Dichloride (MDC) exceeds demand by **100,000 tons**, ensuring easy procurement for chloromethane requirements. * **Long-term Mineral Access:** Annual contracts for fluorspar are supported by global reserves estimated to last **90 to 100 years**. ## D. Pricing & Pass-through * **Margin Protection:** Robust pass-through mechanism allows for **100% recovery** of raw material and logistics cost increases. * **Transmission Lag:** Cost recovery is subject to a systematic lag of **30 to 45 days**, which may impact short-term margins during periods of high volatility. --- # 5. Regulatory & Industry Risks ## A. Key Figures * National HFC Quota (Est.): 115–125 KT per annum · 110,000–120,000 tonnes total * **Installed Capacity (India):** **~50,000 tons** current existing * **Sulphur Price:** **₹38 – ₹40 per kg** FY26 (vs. **₹30 per kg** FY25) ## B. HFC Quota Allocation * **Regulatory Timeline:** The national HFC quota system becomes officially applicable on **January 1, 2028**, following a "free year" in **2027** where production and supply of HFC-32 will remain unrestricted. * **Allocation Strategy:** Quotas are expected to be issued proportionately based on the operational production capacity of units as of the **2028** freeze date, aligning with the Montreal Protocol phase-down through **2037**. * **Framework Uncertainty:** While the government has not finalized if allocations will be product-based or GWP-based, management anticipates a model similar to the **Chinese concept**. * **Compliance Confidence:** Despite incumbent competitors holding historical HCFC baselines, the company is relying on regulatory clauses that prioritize **operational capacity by 2028** for future quota eligibility. ## C. Input Cost Volatility * **Raw Material Headwinds:** Profitability has been impacted by a significant surge in sulphur prices driven by the **West Asian crisis**. * **Supply Chain Resilience:** Despite price volatility, the company maintains steady supply for its sulphuric acid plants through established sourcing channels. ## D. Competitive Market Entry * **Policy Tailwinds:** Management views current government frameworks as a strategic push to encourage new domestic entrants under **"Make in India"** initiatives to serve local demand. * **Incumbent Advantage:** Market concerns persist regarding the dominance of established players (SRF, GFL, Navin) who possess active production records during the **2024-2026** observation window. --- # 6. Guidance & Outlook ## A. Key Figures * **Revenue Target (2-3 Years):** **₹1,600 Cr+** * **Revenue Target (FY28):** **₹1,600 Cr** – **₹2,000 Cr** * **Revenue Target (5 Years):** **₹3,000 Cr** – **₹3,500 Cr** * **HFC-32 Global Demand:** **380 KT** (2025) · **485 KT** (2030) (5% CAGR) * **HFC-32 Domestic Demand:** **22–23 KT** (Current) · **45–50 KT** (4-5 Years) (16-17% CAGR) ## B. Revenue Targets & Strategic Drivers * **Multi-Year Scaling:** Management projects significant top-line expansion over the next five years, underpinned by a robust pipeline of new products and peak utilization of upcoming capacities. * **Operational Catalysts:** Growth is anchored by long-term customer contracts and the strategic operationalization of a new **Hydrofluoric Acid (HF)** plant. * **Resilience Amid Volatility:** Despite geopolitical headwinds in Western Asia, outlook remains positive due to strong order visibility and downstream expansion. ## C. Commissioning Timelines * **Refrigerant Gas Expansion:** The **20,000 MT** R-32 plant is currently **50% complete**, with commissioning slated for **Q3 FY27** to capitalize on "Make in India" tailwinds. * **Simultaneous Capacity Addition:** A new HF plant and an additional **20,000 MT** solar grade DHF facility are scheduled for concurrent commissioning by **June 2027**. ## D. Sector Growth Projections * **Solar Segment Tailwinds:** Solar grade DHF demand is forecasted to grow **6.5x to 7x** as India’s solar capacity scales from **36 GW to 216 GW** over five years. * **Air Conditioning Under-penetration:** With domestic AC penetration at only **8%** (vs. 65% in China), refrigerant gas demand is poised for a **4x to 6x** increase. * **Ancillary Sector Momentum:** Steady demand growth persists in the steel sector (**5-6%**) and the pharma/agrochemical segments (**6-7%**).